Below is Validea's guru fundamental report for INTUITIVE SURGICAL, INC. (ISRG). Of the 22 guru strategies we follow, ISRG rates highest using our P/B Growth Investor model based on the published strategy of Partha Mohanram. This growth model looks for low book-to-market stocks t
While the S&P 500 has climbed by about 19% so far in 2023, a lot of that has been driven by the gains of a relatively small number of massive tech companies with exposure to artificial intelligence (AI) trends. The stellar performances of companies including Nvidia, Apple, Am
Since its inception, Social Security has been a pivotal part of many Americans' retirement planning. After decades of paying Social Security taxes, it's a way for retirees to reap the benefits with a safety net of income in their golden years.As people near retirement, it's commo
December S&P 500 futures (ESZ23) are up +0.04%, and December Nasdaq 100 E-Mini futures (NQZ23) are down -0.10% this morning as investors looked ahead to comments from Fed Chair Jerome Powell for more clues about the path of interest rates, while also gearing up for U.S. factory activity data.
Smart investors study and understand trends. Industry trends, financial trends, and market trends can all play a part in determining which stocks rise and fall over time.
(RTTNews) - Medina, Minnesota-based Polaris Inc. is recalling about 5100 units of Patriot snowmobiles as they can have a faulty clutch posing injury hazards to consumers, according to the U.S Consumer Product Safety Commission or CPSC.
Ross Stores (NASDAQ: ROST) had a really strong third quarter in 2023. The headline-grabbing number was 5% same-store sales growth. That was very good, but there are some nuances here. And while current shareholders should be pleased by the company's success, investors looking at
Drugmaker Novo Nordisk paid U.S. medical professionals at least $25.8 million over a decade in fees and expenses related to its weight-loss drugs, a Reuters analysis found. It concentrated that money on an elite group of obesity specialists who advocate giving its powerful and expensive drugs to tens of millions of Americans.
It's quite easy to list the attributes that income investors love to see in a stock. Obviously, a juicy dividend yield is high on the list. A reliable payout ranks way up there, too. And while income is paramount, even dividend investors enjoy share-price appreciation.
Once upon a time, I was convinced that Elon Musk was a genius with a world-changing vision. I bought my first Tesla (NASDAQ: TSLA) shares in the summer of 2014, citing five unique company qualities. I liked the company's radical approach to research and development, the game-chan
Shiba Inu (CRYPTO: SHIB) is one of the most popular cryptocurrency tokens at the speculative end of the industry. In 2021 it delivered one of the greatest returns in financial market history; a perfectly timed investment of just $3 on Jan. 1 would have made you a millionaire by t
Global stocks edged up on Friday, having closed out their best month in three years the day before, as investor confidence that interest rates will fall next year has lured cash into equities, cryptocurrencies and gold at the expense of the dollar.
Gold prices were set for a third straight weekly gain after data showing easing inflation raised expectations that the U.S. Federal Reserve would soon start cutting interest rates, with Chair Jerome Powell's speech later on Friday in focus.
Shopify (NYSE: SHOP) stock is expensive right now. Shares of the barely profitable e-commerce outfit trade at 74 times next year's expected earnings. The company's pace of sales growth is slowing down, too, even if only because its past growth has made for tougher comparisons now
I'm going way off the beaten path to highlight two beaten-down growth stocks today. MKS Instruments (NASDAQ: MKSI) and Trex (NYSE: TREX) aren't household names by any means. But they each have a long history of growth and strong shareholder returns -- the present downturn notwith
Pakistan's Supreme Court began hearings on Friday on a petition by rights activists seeking to halt deportation of Afghan refugees, a lawyer said, as authorities are combing refugee settlements in an effort to find and send home thousands.
U.S. data is moving against the dollar, which could force the Fed to cut rates as markets expect, and next Friday's jobs report will play a key role in developing expectations.
AstraZeneca on Friday said it would discontinue two late-stage trials looking at the potential benefits of its drug Lokelma in the management of hyperkalaemia across the cardiorenal spectrum.